Molecular Oncology
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 4.5 | Q2 | 69.1% | 1.738 | Q1 | 93.9% |
| 2024 | 4.5 | Q2 | 74.5% | 1.957 | Q1 | 95.1% |
| 2023 | 5.0 | Q1 | 76.6% | 1.940 | Q1 | 95.4% |
| 2022 | 6.6 | Q1 | 81.6% | 1.778 | Q1 | 94.8% |
| 2021 | 7.4 | Q1 | 81.5% | 1.773 | Q1 | 94.9% |
| 2020 | — | — | 2.332 | Q1 | 96.6% | |
| 2019 | — | — | 2.273 | Q1 | 96.5% | |
| 2018 | — | — | 2.672 | Q1 | 97.0% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
1878-0261
ISSN
1574-7891
country
NLcoverage
2007-2026